Prof. Dr. Veysel Sabri Hançer 1995 yılında Karşıyaka Lisesi’nden (Erkek Lisesi, İzmir), 1999 yılında ise Ege Üniversitesi Fen Fakültesinden mezun oldu. Yüksek Lisansını 2001 yılında Ege Üniversitesi’nde tamamlamasının ardından, 2009 yılında İstanbul Üniversitesi Moleküler Biyoloji ve Genetik programında doktorasını (PhD) tamamladı. Halen, İstinye Üniversitesi Tıp Fakültesi, Tıbbi Biyoloji Anabilim Dalı başkanıdır. H-indeksi 13 olan Dr. Hançer’in çok sayıda uluslararası bilimsel makalesi ve ulusal/uluslararası ödülü bulunmaktadır. Human Genetics&Embriology Dergisi Yayın Kurulu Üyesi, Turkish Journal of Hematology dergisinin editörüdür. Türk Hematoloji Derneği ve Tıbbi Biyoloji ve Genetik Derneği üyesidir. İyi derecede İngilizce konuşur ve yazar. Evli ve iki çocuk babasıdır.
Araştırma Alanları
- Kanser Genetiği
- Genomik ve Proteomik analizler
- Moleküler Hematoloji
- Nadir Genetik Hastalıklar
Çalışma Alanları
- Sağlık Bilimleri Temel Alanı
- Tıbbi Biyoloji
- Novel Pathological Mutation (c.870 GA, p.Trp290stop) in ARSB of Mucopolysaccharidosis Type VI Patients, 2019
- Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation, 2019
- Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients, 2019
- Evaluation of Tissue Factor -603 A/G Promoter Gene Polymorphism in Thrombotic Processes in Patients with Antiphospholipid Syndrome, 2019
- Prevalence of human papilloma virus types in Turkish and Albanian women, 2018
- Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment, 2018
- A novel ATP6V0A2 mutation causing recessive cutis laxa with unusual manifestations of bleeding diathesis and defective wound healing, 2018
- β globin mutations in Turkish, Northern Iraqi and Albanian patients with β thalassemia major, 2018
- Three Factor 11 mutations associated with Factor XI deficiency in a Turkish family, 2018
- A Novel Ganciclovir Resistance Mutation in the UL97 Gene of the HHV-5 in an Adult Hematopoietic Stem Cell Transplant Recipient, 2017
- Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up, 2017
- Three Novel Calreticulin Mutations in Two Turkish Patients, 2017
- P-selectin glycoprotein ligand-1 variable number of tandem repeats polymorphism in young myocardial infarction patients, 2016
- Glycoprotein Ibα Kozak polymorphism in patients presenting with early-onset acute coronary syndrome., 2016
- Dual effects of testosterone in Behcet s disease implications for a role in disease pathogenesis, 2016
- Prophylactic Eculizumab Use in Kidney Transplantation A Review of the Literature and Report of a Case with Atypical Hemolytic Uremic Syndrome, 2015
- Non invasive prenatal diagnosis of fetal RhD by using free fetal DNA, 2015
- Renal outcome with eculizumab in two diarrhea-associated haemolytic-uremic syndrome cases with severe neurologic involvement., 2014
- The Relationship between P Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome A Pilot Case Control Study, 2014
- Coronary artery ectasia is associated with the c 894G T Glu298Asp polymorphism of the endothelial nitric oxide synthase gene, 2014
- MPL W515L K mutations in chronic myeloproliferative neoplasms, 2013
- Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab, 2013
- Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation, 2012
- The clinical significance of JAK2V617F mutation for Philadelphia negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis, 2012
- Glycoprotein Ib alpha Kozak polymorphism in ischemic stroke, 2012
- The impact of platelet membrane glycoprotein Ib alpha and Ia IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome, 2012
- Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm, 2012
- Overexpression of Fc Mu Receptor FCMR TOSO Gene In Chronic Lymphocytic Leukemia Patients, 2012
- ADAMTS 13 gene expression in antiphospholipid syndrome, 2011
- Comparison of KRAS Mutation Tests in Colorectal Cancer Patients, 2011
- Polymorphisms of the angiotensin converting enzyme and angiotensinogen gene in patients with atrial fibrillation, 2011
- Activation induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia, 2011
- Cytotoxic T Lymphocyte Antigen 4 CTLA 4 A49G Polymorphism and Autoimmune Blood Diseases, 2010
- Impact of genetic polymorphisms on platelet function and aspirin resistance, 2010
- The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome, 2010
- Angiotensin converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia is DD genotype helpful in predicting syncope risk, 2008
- The association of P selectin glycoprotein ligand 1 VNTR polymorphisms with coronary stent restenosis, 2007
- The association between factor XIII Val34Leu polymorphism and early myocardial infarction, 2006
- Turkish population data on the factor XIII Val34Leu glycoprotein GP Ib Kozak and P selectin glycoprotein ligand 1 PSGL 1 loci, 2005
- Factor XIII Val34Leu polymorphism does not contribute to the prevention of trombotic complication in patients with antiphospholipid syndrome, 2004
- Kruppel Like Factor 4 Gene Expression and DNA Methylation in Patinet with Type 2 Diabetes and Diabetic Nephropathy, 2021
- Two novel calreticulin mutations in a turkish patient with primary myelofibrosis: c.1116delA and c.1120A>C., 2015
- Two Pediatric Cases of Essential Thrombocytopenia Characterized By Extremely Rare Mutations., 2015
- The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma., 2014
- Is the Glu298Asp polymorphism of Endothelial Nitric Oxide Synthesis Increase the Risk of Stent Thrombosis?, 2013
- Investigation of Arrhythmia Markers and KCNJ8-S422L Gene Mutation in a Population with Early Repolarization Pattern on ECG, 2013
- The clinical significance of JAK2 V617F mutation for Philedelphia-negative chronic myeloproliferative diseases in patients with splanchnic vein thrombosis, 2011
- Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome., 2010
- Tissue factor -603A/G polymorphism and tissue factor levels in patients with antiphospholipid syndrome., 2009
- ADAMTS-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome, 2008
- P-selectin glycoprotein ligand 1 VNTR polymorphisms in systemic sclerosis, 2007
- The association between factor XIII Val34Leu polymorphism and early myocardial infarction, 2006
- CTLA-4 A49G polymorphism and autoimmune blood diseases,
- CTLA-4 A49G polymorphism and autoimmune blood diseases,
- The effect of stem cell transplantation on social and economic status in a developing country on family basis, 2013
- HLA Full Match Donors., 2013
- Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome, 2013
- en iyi çalışma ödülü, 2002
- Genç Katılımcı Ödülü, 2003
- en iyi çalışma ödülü, 2004
- genç katılımcı ödülü, 2004
- başarılı araştırıcı ödülü, 2004
- bilimsel yayınları teşvik programı ödülü, 2005
- en iyi çalışma ödülü, 2006
- genç katılımcı ödülü, 2008
- en iyi çalışma ödülü, 2010
